P N Krishna Kumar¹, Shabnam Narayanan^2*

{¹Assosciate Professor, Department of Cardiothoracic and Vascular Surgery} {²Assistant Professor, Department of Pharmacology} Government Medical College, Kannur, Pariyaram, Kerala, INDIA.

Email: chapps82@yahoo.com

REFERENCES

1. Federmann M, Hess OM. Differentiation between systolic and diastolic dysfunction. Eur Heart J [Internet]. 1994 Dec [cited 2015 Oct 26];15 Suppl D:2–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/7713107
2. Diller PM, Smucker DR, David B, Graham RJ. Congestive heart failure due to diastolic or systolic dysfunction. Frequency and patient characteristics in an ambulatory setting. Arch Fam Med [Internet]. Jan [cited 2015 Oct 26];8(5):414–20. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10500514
3. Classification of Functional Capacity and Objective Assessment [Internet]. [cited 2015 Nov 2]. Available from: http://my.americanheart.org/professional/StatementsGuidelines/ByPublicationDate/PreviousYears/Classification-of-Functional-Capacity-and-Objective-Assessment_UCM_423811_Article.jsp#.Vjb42rcrLIU
4. Lee S, Khurana R, Leong KTG. Heart failure in Asia: the present reality and future challenges. Eur Hear J Suppl [Internet]. 2012 Feb 23 [cited 2015 Oct 4];14(suppl A):A51–2. Available from: http://eurheartjsupp.oxfordjournals.org/content/14/suppl_A/A51.abstract
5. Manuscript A. NIH Public Access. Changes. 2012;29(6):997–1003.
6. Cleland JGF. What is the optimal medical management of ischaemic heart failure? Br Med Bull [Internet]. 2001 Oct 1 [cited 2015 Oct 26];59(1):135–58. Available from: http://bmb.oxfordjournals.org/content/59/1/135.long
7. Fragasso G, Perseghin G, De Cobelli F, Esposito A, Palloshi A, Lattuada G, et al. Effects of metabolic modulation by TMZ on left ventricular function and phosphocreatine/adenosine triphosphate ratio in patients with heart failure. Eur Heart J. 2006;27(8):942–8.
8. Fragasso G, Palloshi A, Puccetti P, Silipigni C, Rossodivita A, Pala M, et al. A Randomized Clinical Trial of TMZ, a Partial Free Fatty Acid Oxidation Inhibitor, in Patients With Heart Failure. J Am Coll Cardiol. 2006;48(5):992–8.
9. Di Napoli P, Taccardi AA, Barsotti A. Long term cardioprotective action of TMZ and potential effect on the inflammatory process in patients with ischaemic dilated cardiomyopathy. Heart [Internet]. 2005 Feb 1 [cited 2015 Oct 11];91(2):161–5. Available from: http://heart.bmj.com/content/91/2/161.abstrac
10. Vitale C, Wajngaten M, Sposato B, Gebara O, Rossini P, Fini M, et al. TMZ improves left ventricular function and quality of life in elderly patients with coronary artery disease. Eur Heart J [Internet]. 2004 Oct 2 [cited 2015 Nov 2];25(20):1814–21. Available from: http://eurheartj.oxfordjournals.org/content/25/20/1814.long.